An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
Clinical trial NCT02319460 · COMPLETED
Trial details
- NCT number
- NCT02319460
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-04-24
- Primary completion
- 2020-06-30
- Enrollment
- 2238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.